✨ Your Portfolio is fetched and updated from zerodha.
Micro
Market Cap
₹465 Cr.
P/E
73.90

Key Ratios

Market cap
Market cap
465 Cr
PE
PE
73.90
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
4.38
ROCE (%)
ROCE (%)
6.33
Div Yield (%)
Div Yield (%)
0.66
Sales
Sales
326 Cr
OPM (%)
OPM (%)
-2.60 %
Debt to Equity
Debt to Equity
-
About
Albert David is in the Miscellaneous sector with a M.cap of 465.00 Cr and a PE ratio o… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Albert David Ltd. Business

Albert David Limited, a leading Indian drug manufacturer based in Kolkata, offers a wide range of pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and medical disposables. It is a key subsidiary of the Kothari Group, known for its advanced R&D and manufacturing capabilities.

Albert David major competitors are Medicamen Biotech, Jenburkt Pharma, Brooks Laboratories, Fredun Pharma, Zim Laboratories, Lyka Labs, Trident Lifeline.
Market Cap of Albert David is ₹465 Crs.
While the median market cap of its peers are ₹409 Crs.

Albert David seems to be less financially stable compared to its competitors.
Altman Z score of Albert David is 2.92 and is ranked 7 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material